Compare PKOH & HQL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PKOH | HQL |
|---|---|---|
| Founded | 1907 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Investment Managers |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 526.0M | 521.8M |
| IPO Year | 1994 | N/A |
| Metric | PKOH | HQL |
|---|---|---|
| Price | $39.06 | $19.25 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $37.00 | N/A |
| AVG Volume (30 Days) | 61.1K | ★ 115.4K |
| Earning Date | 05-06-2026 | 01-01-0001 |
| Dividend Yield | 1.69% | ★ 11.56% |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.57 | ★ 0.79 |
| Revenue | ★ $1,599,100,000.00 | N/A |
| Revenue This Year | $7.87 | N/A |
| Revenue Next Year | $3.42 | N/A |
| P/E Ratio | $67.16 | ★ $24.09 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $15.52 | $12.72 |
| 52 Week High | $38.44 | $19.33 |
| Indicator | PKOH | HQL |
|---|---|---|
| Relative Strength Index (RSI) | 75.71 | 72.17 |
| Support Level | $19.32 | $16.51 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 1.37 | 0.39 |
| MACD | 0.28 | 0.24 |
| Stochastic Oscillator | 89.77 | 89.54 |
Park-Ohio Holdings Corp is a diversified international company offering its clients supply chain management outsourcing services, capital equipment used on their production lines, and manufactured components used to assemble their products. The company operates through three reportable segments: Supply Technologies, Assembly Components, and Engineered Products. Maximum revenue is generated from the Supply Technologies segment, which is mainly engaged in sourcing, planning, and procurement of several production components, including fasteners, pins, nuts, bolts, valves, hoses, wire harnesses, clamps and fittings, etc. Geographically, the company generates maximum revenue from its business in the United States, followed by Europe, Asia, Mexico, Canada, and other regions.
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mainly in securities of life sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser to have the potential for above-average growth.